DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence

100 Folgen

1. Drug Excipient Business Development Reports now Available on Amazon

   Vom: 15.2.2024
2. Revolutionizing Patent Landscaping: A Human-Supervised AI Approach to Identify Tech Clusters

   Vom: 30.1.2024
3. Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book

   Vom: 22.1.2024
4. An AI Approach to Generate Novel Pharmaceuticals using Patent Data

   Vom: 16.1.2024
5. NPR on how low Drug Prices can Cause Shortages

   Vom: 9.1.2024
6. Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals

   Vom: 8.1.2024
7. Decoding Pfizer’s Portfolio: A New Model for Precision in Pharma Investments

   Vom: 11.12.2023
8. Navigating Legal Waters: Study Delves into Inequitable Conduct in Drug Patent Cases

   Vom: 17.11.2023
9. AI-Driven Strategies: Pharma’s Answer to Patent Expirations

   Vom: 12.11.2023
10. Maximizing Intellectual Property Value in the Biomedical Sector: A Case Study on Rucaparib Patents

    Vom: 6.11.2023
11. Advancements in In Silico ADMET Modeling: A 20-Year Journey of Machine Learning in Drug Discovery at Bayer Pharma

    Vom: 30.10.2023
12. List of research papers citing DrugPatentWatch

    Vom: 25.10.2023
13. Influencers of Generic Drug Utilization

    Vom: 16.10.2023
14. Reviving an R&D Pipeline

    Vom: 9.10.2023
15. Factors that May Predict the Likelihood of Generic Drug Marketing Applications

    Vom: 2.10.2023
16. Measuring Patent Value Indicators

    Vom: 25.9.2023
17. Maximizing Drug Patents’ Value: Strategies for Biomedical Companies

    Vom: 18.9.2023
18. From Expert AI to Snackable AI: A New Era in Pharma, as Seen by Sanofi’s CEO

    Vom: 12.9.2023
19. Understanding Patent Term Extensions: An Overview

    Vom: 12.9.2023
20. Pharmacists Can Play Key Role in Drug Repurposing

    Vom: 5.9.2023